Evidence map›Paper›PMID 42098076›Full record

ArticleCell death discovery2026

Induction of stress granules alleviates programmed cell death induced by lysosomal damage during NK cell cryopreservation.

Yang Liu, Xiaolong Liu, Guangyuan Wu, Xin Wang, Kuo Yu, Hailong Wang, Xin Sun, Zhongyao An, Hongrui Xu, Linlin Zhao and 5 more

Abstract read
In one paragraph

Article in Cell death discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yang Liu *NHC Key Laboratory of Cell Transplantation, Harbin Medical University, Harbin, China.
Xiaolong Liu *NHC Key Laboratory of Cell Transplantation, Harbin Medical University, Harbin, China.
Guangyuan Wu *NHC Key Laboratory of Cell Transplantation, Harbin Medical University, Harbin, China.
Xin WangNHC Key Laboratory of Cell Transplantation, Harbin Medical University, Harbin, China.
Kuo YuKey Laboratory of Animal Cellular and Genetics Engineering of Heilongjiang Province, College of Life Science, Northeast Agricultural University, Harbin, China.
Hailong WangNHC Key Laboratory of Cell Transplantation, Harbin Medical University, Harbin, China.
Xin SunNHC Key Laboratory of Cell Transplantation, Harbin Medical University, Harbin, China.
Zhongyao AnNHC Key Laboratory of Cell Transplantation, Harbin Medical University, Harbin, China.
Hongrui XuNHC Key Laboratory of Cell Transplantation, Harbin Medical University, Harbin, China.
Linlin ZhaoDepartment of Blood Transfusion, First Affiliated Hospital, Harbin Medical University, Harbin, China.
Ce ShiNHC Key Laboratory of Cell Transplantation, Harbin Medical University, Harbin, China.
Song Guo ZhengDepartment of Immunology, School of Cell and Gene Therapy, Songjiang Research Institute, Shanghai Songjiang District Central Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Mingli HuangNHC Key Laboratory of Cell Transplantation, Harbin Medical University, Harbin, China. doctor_hml@163.com.
Zhiren ZhangNHC Key Laboratory of Cell Transplantation, Harbin Medical University, Harbin, China. zhirenz@163.com.
Zhenkun WangNHC Key Laboratory of Cell Transplantation, Harbin Medical University, Harbin, China. zhenkunwang@hrbmu.edu.cn.ORCID http://orcid.org/0000-0003-4894-0029

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82101929
6 · The paper itself

Abstract

Natural killer (NK) cell-based therapies are under assessment for the treatment of various cancers due to their intrinsic ability to distinguish between malignant and healthy cells in an allogeneic context, enabling off-the-shelf manufacturing possibilities. However, cryopreservation reduces both the recovery and function of NK cells, thereby limiting their therapeutic feasibility. In this study, we evaluated three cryoprotectants (CryoStor 10; ZKCELL FM-01; FBS + DMSO) for the cryopreservation of NK cells. Post-thaw viability, ATP levels, and cytotoxicity were assessed and found to have persistent differences between cryopreserved and fresh cells. Transmission electron microscopy, flow cytometry, and Western blot analysis revealed a complex mode of cell death in cryopreserved cells, which could be partially mitigated by adding some death inhibitors. We further investigated the effects of centrifugation on thawed cells, identifying lysosomal stability as a key determinant of cell death. Pretreatment with low-dose LLOMe prior to cryopreservation induced stress granule formation, stabilizing lysosomes and improving cell recovery rates without compromising effector functional capacity. These findings offer new insights for optimizing NK cell cryopreservation and facilitating their clinical application.

Identifiers

PMID42098076
PMCPMC13319456

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.